Chong Kun Dang Pharmaceutical

Novartis Inks Potential $1.3B Contract with Korean Biotech for Small Molecule
BioSpace
Tue, 11/7/23 - 10:05 am
Novartis
Chong Kun Dang Pharmaceutical
small molecule drugs